Futura Medical Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Futura Medical has been growing earnings at an average annual rate of 6.8%, while the Pharmaceuticals industry saw earnings declining at 5.2% annually. Revenues have been growing at an average rate of 93.3% per year.
Anahtar bilgiler
6.8%
Kazanç büyüme oranı
19.2%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 14.1% |
Gelir büyüme oranı | 93.3% |
Özkaynak getirisi | -48.1% |
Net Marj | -44.7% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)
Sep 13We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth
Apr 17Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation
Jan 05Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?
Jul 28We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully
Mar 18We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate
Sep 25Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation
May 10We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow
Jan 10What We Learned About Futura Medical's (LON:FUM) CEO Compensation
Dec 21Gelir ve Gider Dağılımı
Futura Medical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 8 | -4 | 8 | 2 |
31 Mar 24 | 6 | -5 | 7 | 2 |
31 Dec 23 | 3 | -7 | 7 | 2 |
30 Sep 23 | 2 | -6 | 5 | 3 |
30 Jun 23 | 2 | -5 | 4 | 3 |
31 Mar 23 | 1 | -5 | 3 | 4 |
31 Dec 22 | 0 | -6 | 3 | 4 |
30 Sep 22 | 0 | -6 | 3 | 4 |
30 Jun 22 | 0 | -6 | 2 | 4 |
31 Mar 22 | 0 | -5 | 2 | 4 |
31 Dec 21 | 0 | -5 | 2 | 4 |
30 Sep 21 | 0 | -4 | 2 | 3 |
30 Jun 21 | 0 | -3 | 1 | 2 |
31 Mar 21 | 0 | -3 | 1 | 2 |
31 Dec 20 | 0 | -2 | 1 | 2 |
30 Sep 20 | 0 | -4 | 1 | 4 |
30 Jun 20 | 0 | -6 | 1 | 6 |
31 Mar 20 | 0 | -7 | 1 | 8 |
31 Dec 19 | 0 | -9 | 1 | 10 |
30 Sep 19 | 0 | -9 | 1 | 10 |
30 Jun 19 | 0 | -8 | 1 | 9 |
31 Mar 19 | 0 | -7 | 1 | 8 |
31 Dec 18 | 0 | -6 | 1 | 6 |
30 Sep 18 | 0 | -5 | 1 | 5 |
30 Jun 18 | 0 | -4 | 1 | 4 |
31 Mar 18 | 0 | -4 | 1 | 4 |
31 Dec 17 | 0 | -4 | 1 | 4 |
30 Sep 17 | 0 | -4 | 1 | 4 |
30 Jun 17 | 0 | -3 | 1 | 3 |
31 Mar 17 | 0 | -4 | 1 | 3 |
31 Dec 16 | 0 | -4 | 1 | 4 |
30 Sep 16 | 0 | -4 | 1 | 4 |
30 Jun 16 | 0 | -5 | 1 | 4 |
31 Mar 16 | 0 | -5 | 1 | 4 |
31 Dec 15 | 0 | -5 | 1 | 5 |
30 Sep 15 | 0 | -5 | 1 | 4 |
30 Jun 15 | 0 | -4 | 1 | 4 |
31 Mar 15 | 0 | -4 | 1 | 3 |
31 Dec 14 | 0 | -3 | 1 | 2 |
30 Sep 14 | 0 | -3 | 1 | 2 |
30 Jun 14 | 0 | -3 | 1 | 2 |
31 Mar 14 | 0 | -2 | 1 | 2 |
31 Dec 13 | 0 | -2 | 1 | 2 |
Kaliteli Kazançlar: FUM is currently unprofitable.
Büyüyen Kar Marjı: FUM is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: FUM is unprofitable, but has reduced losses over the past 5 years at a rate of 6.8% per year.
Büyüme Hızlandırma: Unable to compare FUM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: FUM is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (4.5%).
Özkaynak Getirisi
Yüksek ROE: FUM has a negative Return on Equity (-48.05%), as it is currently unprofitable.